HUGE News - $TBRIF might see an interesting session as the company’s AI-powered Digital Cough Technology (DCT) is currently being considered as a partner technology for a new innovative, disruptive chronic cough drug US-based clinical trial.

It’s a bug news and may be a big turnaround for $TBRIF. The stock is already in a multi-year breakout.

https://www.newsfilecorp.com/release/220173/T...ical-Trial